Blood thinner vs usual care for new heart rhythm after bypass surgery
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether using a blood thinner in people with new, temporary atrial fibrillation after CABG (heart bypass surgery) can reduce harmful outcomes compared with standard treatment. It may help prevent stroke or other complications if your rhythm problem fits the trial’s timing and risk profile.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and had isolated CABG for coronary artery disease
- You developed atrial fibrillation after surgery that lasts over 60 minutes or comes back within 7 days
- You have no past history of atrial fibrillation (permanent, persistent, or occasional)
- You do not already have a reason to take long-term blood thinners
- You cannot be scheduled to take two anti-platelet medicines after surgery (DAPT)
- You can safely take an approved blood thinner and are able to consent and follow the study plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different blood-thinner (“antithrombotic”) strategies in people with atrial fibrillation or flutter who recently had a stent placed (PCI). It aims to find a plan that lowers clot risk while keeping bleeding risk as low as possible.
This trial tests whether taking a blood thinner can lower the risk of stroke in people who had atrial fibrillation (an irregular heartbeat) that happened temporarily around a stressful illness or surgery. It looks especially at people at higher risk for stroke after that episode.
This trial tests whether it is safe for patients with atrial fibrillation to stop taking blood thinners after they have had heart surgery, including closure of the left atrial appendage. The goal is to see if these patients can avoid long-term medication without increasing the risk of stroke.
This trial tests whether patients who receive a special device to close a hole in the heart (to prevent stroke from irregular heartbeat) can safely take fewer blood-thinning medications afterward. The study compares taking a standard blood thinner for 3 months versus taking aspirin only, to see which approach works best with fewer bleeding risks.
This study looks at whether a lower-dose blood thinner works as well as the usual recommended anti-clot treatment after a procedure that closes off the heart’s left atrial appendage. It may help reduce bleeding risk while still preventing dangerous blood clots.
This trial tests how well blood thinners (anticoagulants) work to dissolve clots in the heart of people with atrial fibrillation (an irregular heartbeat). It aims to find the best treatment for these clots before more serious complications occur.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.